About Us
Nanophysics & Beyond
Curadigm
The Management
Our Commitments
Healthcare Professionals
Scientific Publications
Patients
Patient Engagement
Investors
Corporate Presentation
Financial Calendar
Regulated Information
SEC Filings
Annual General Meetings
Shareholder Corner
Press Releases
Congresses & Events
Nanotalks
NBTXR3 Development
R&D Day
Our Expert Videos
Nanoblog
From Curie to Nano
Contact & Newsletter
Medical Device Vigilance – Pharmacovigilance
Medical Information
Join Us
Nous vous informons que ce site est conforme à la législation française actuelle sur les dispositifs médicaux.
Continuer
Rester sur la page
Nanobiotix Code of Business Conduct and Ethics
Appointment and compensation committee charter and internal rules of procedure
11 December 2020
Bordereau d’amendement n° D. 20-0339-A02 du 11 décembre 2020
11 December 2020
Nanobiotix Code of Business Conduct and Ethics
Published by
Julie Ficheux
on
11 December 2020
No translations available for this page